mg

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

The Silver Age of Antibiotics

By: Andrew Leong, Staff Writer -- This year, the FDA approved three new antibiotics to treat acute bacterial skin and…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

A Brave New World for Lipid Management

By: Amrita Singh, PharmD Candidate c/o 2015 - Last November, the American College of Cardiology and the American Heart Association…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

The Use of Methadone in Neuropathic Pain

By: Neal Shah, PharmD, MD/PhD Student c/o 2021, West Virginia University School of Medicine - Methadone is a powerful long-acting…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Does Moxifloxacin Increase the Risk of Dysglycemia?

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

A Close Concurrence on Certolizumab (Cimzia®)

By: Sang Hyo Kim, Staff Editor - This year, on July 23rd, FDA advisers voted 7 to 6, with one…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Understanding Opioid Overdose

By: Aleena Cherian, PharmD Candidate c/o 2014 - Although opioid analgesics are among the most effective drugs to treat pain,…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Can a Pharmacist Prevent the Next Pileup?

By: Moisey Rafailov, PharmD Candidate c/o 2015 - It was early in the morning on New York’s Route 684 when…

13 years ago

Purple Glove Syndrome

By: Sharon Janak, PharmD Candidate c/o 2013 - How can we distinguish between vascular injury and Purple Glove Syndrome (an…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

The Opioid Debate: PROP and PROMPT Battle Away

By: Tamara Yunusova - On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Adverse Events from Ingestion of OTC Eye Drops and Nasal Sprays

By Tasnima Nabi, PharmD Candidate c/o 2016 - The FDA has issued warnings on accidental ingestion of over-the-counter eye drops…

14 years ago

Are You Prepared for RSV Season?

By: Mahdieh Danesh Yazdi, Associate Student Editor - Many of us have prepared for influenza season by receiving the flu…

14 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago

Ivacaftor (KalydecoTM): Targeting the Core of Cystic Fibrosis

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…

14 years ago

Low-dose SSRIs for the Overly Sensitive Esophagus

By Sunhae Chang, PharmD Candidate c/o 2013 - When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux…

14 years ago

Duloxetine’s Effect on Blood Glucose Levels

By: Neal Shah, Co-Editor-in-Chief - Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US…

14 years ago

Student Spotlight: Felipe Camacho

By Nandini Puranprashad, Pharm D. Candidate c/o 2013 - Felipe Camacho is a 6th year student at the University of…

14 years ago

Matching Challenge: Over-the-Counter Products

By: Mohamed Dungersi, Associate Student Editor -  Match the following herbal products with their correct description: A. This product has…

14 years ago

Indications for Dialysis: A Mnemonic And Explanation

By: Neal Shah, Co-Editor-in-Chief -  Dialysis is the removal of substances from intravascular circulation by filtration.1  Typically, dialysis is ordered…

14 years ago

The Role of N-Acetylcysteine in Contrast Induced Nephropathy

By: Neal Shah, Co-Editor-In-Chief - Contrast dyes enhance imaging for computer tomography (CT), magnetic resonance (MR), and X-rays.1  Dyes usually…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

Understanding Diabetic Ketoacidosis

By: Mohamed Dungersi, Associate Student Editor -  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…

14 years ago

The Pathophysiology of Syndeham’s Chorea

By: Neal Shah, Co Editor-In-Chief - Dyskinesias are abnormal, involuntary movement disorders.  Subsets of dyskinesias include choreas and atheosis.  Chorea…

14 years ago

Dr. Oz and Raspberry Ketones

By: Lila Ahmed, Pharm.D. Candidate c/o 2013 - Whether you wish to admit it or not, all of us have…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

The 2012 Update of the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

By: Shannon Tellier - Medication related problems can be reduced in older adults if the Beers Criteria were utilized by…

14 years ago

HMG-CoA Reductase Inhibitors And Memory Loss

By: Yufan (Frank) Liu, Pharm.D. Candidate c/o 2013 - Results of numerous epidemiological studies have indicated that having high serum…

14 years ago

FDA Makes Label Changes to Statins

By: Mohamed Dungersi - On February 28, the U.S. Food and Drug Administration (FDA) approved important safety label changes for…

14 years ago

Inhaled Caffeine Under Investigation

By: Mahdieh Danesh Yazdi - A few months ago, a new product called AeroShot Pure Energy hit the markets in…

14 years ago